KRAS exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer
Camaj, Peter, Primo, Stefano, Wang, Yan, Heinemann, Volker, Zhao, Yue, Laubender, Ruediger Paul, Stintzing, Sebastian, Giessen-Jung, Clemens, Jung, Andreas, Gamba, Sebastian, Bruns, Christiane Josephine, Modest, Dominik Paul
Published in Future oncology (London, England) (01.07.2015)
Published in Future oncology (London, England) (01.07.2015)
Get full text
Journal Article
Effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib
Gamba, Sebastian, Camaj, Peter, Heinemann, Volker, Laubender, Rüdiger P, Wang, Yan, Zhao, Yue, Stintzing, Sebastian, Giessen, Clemens, Boeck, Stefan, Haertl, Christoph, Bruns, Christiane J, Modest, Dominik P
Published in Anti-cancer drugs (01.04.2015)
Published in Anti-cancer drugs (01.04.2015)
Get more information
Journal Article